Achilles Therapeutics (ACHL) Institutional Ownership $1.07 0.00 (0.00%) (As of 11/22/2024 ET) Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Achilles Therapeutics (NASDAQ:ACHL)CurrentInstitutional OwnershipPercentage56.38%Number ofInstitutional Buyers(last 12 months)7TotalInstitutional Inflows(last 12 months)$9.68MNumber ofInstitutional Sellers(last 12 months)5TotalInstitutional Outflows(last 12 months)$3.30M Get ACHL Insider Trade Alerts Want to know when executives and insiders are buying or selling Achilles Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ACHL Institutional Buying and Selling by Quarter Ad Porter & CompanyWe recommended Nvidia in 2016, now we’re recommending this…The AI boom is just getting started. And the real wealth has still to be made…You must read this new presentation from Porter Stansberry. Achilles Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails11/5/2024 BML Capital Management LLC4,100,002$4.18M2.5%+555.8%9.978% 8/12/2024 XTX Topco Ltd51,660$42K0.0%+239.4%0.126% 8/9/2024 Renaissance Technologies LLC682,734$556K0.0%-32.1%1.662% 8/6/2024 Acadian Asset Management LLC250,825$203K0.0%-10.7%0.610% 5/20/2024 Virtu Financial LLC20,947$26K0.0%-47.1%0.051% 5/17/2024 Artal Group S.A.755,375$944K0.0%-66.5%1.894% Get the Latest News and Ratings for ACHL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Achilles Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/17/2024 Ikarian Capital LLC1,443,181$1.80M0.2%N/A3.619% 5/15/2024 Baker BROS. Advisors LP1,208,775$1.51M0.0%-42.5%3.031% 5/14/2024 StemPoint Capital LP1,385,750$1.73M0.5%N/A3.475% 5/10/2024 Acadian Asset Management LLC280,929$350K0.0%N/A0.704% 3/7/2024 Fcpm Iii Services B.V.2,390,050$2.13M0.6%N/A5.861% 2/14/2024 Vestal Point Capital LP108,083$96K0.0%N/A0.265% 5/12/2023 Forefront Analytics LLC75,625$72K0.0%+147.7%0.185% 2/14/2023 RA Capital Management L.P.1,607,834$1.45M0.0%-67.9%4.107% 11/14/2022 Point72 Asset Management L.P.2,107,595$4.76M0.0%+18.6%5.383% 11/14/2022 Forefront Analytics LLC32,200$72K0.0%N/A0.082% 8/15/2022 Point72 Asset Management L.P.1,776,744$4.48M0.0%+18.4%4.538% 8/15/2022 Kettle Hill Capital Management LLC242,978$612K0.2%N/A0.621% 2/15/2022 Sender Co & Partners Inc.27,690$139K0.1%N/A0.068% 2/14/2022 Point72 Asset Management L.P.1,000,000$5.01M0.0%+100.0%2.463% 2/11/2022 Syncona Portfolio Ltd11,086,909$55.55M53.1%N/A27.306% 11/15/2021 Point72 Asset Management L.P.500,000$3.90M0.0%N/A1.231% 11/15/2021 Sphera Funds Management LTD.242,500$1.89M0.2%-17.0%0.597% 11/15/2021 AXA S.A.279,454$2.18M0.0%+3.8%0.688% 11/15/2021 Farallon Capital Management LLC450,000$3.51M0.0%-54.8%1.108% 11/12/2021 Affinity Asset Advisors LLC100,000$779K0.2%+25.0%0.246% 8/17/2021 Woodline Partners LP77,386$758K0.0%-67.6%0.191% 8/17/2021 Sphera Funds Management LTD.292,194$2.86M0.2%-2.6%0.719% 8/17/2021 Millennium Management LLC196,144$1.92M0.0%-3.3%0.483% 8/16/2021 RA Capital Management L.P.5,014,687$49.09M0.8%+261.1%12.345% 8/16/2021Pinz Capital Management LP16,423$161K0.0%+164.8%0.040% 8/16/2021 Macquarie Group Ltd.40,402$396K0.0%-26.9%0.099% 8/13/2021 Affinity Asset Advisors LLC80,000$783K0.3%+220.0%0.197% 8/13/2021 AXA S.A.269,135$2.64M0.0%N/A0.663% 8/12/2021 JPMorgan Chase & Co.49,405$484K0.0%-92.1%0.122% 8/12/2021 Monashee Investment Management LLC64,697$633K0.1%-48.2%0.159% 8/6/2021 Sei Investments Co.16,220$159K0.0%N/A0.040% 8/3/2021 Peregrine Capital Management LLC225,669$2.21M0.0%-30.0%0.556% 6/10/2021 Perceptive Advisors LLC755,375$12.50M0.2%N/A1.860% 5/19/2021 Squarepoint Ops LLC28,000$463K0.0%N/A0.069% War on Elon Escalates… (Ad)A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it.5/18/2021 Baker BROS. Advisors LP2,591,366$42.89M0.2%N/A6.379% 5/18/2021 Millennium Management LLC202,785$3.36M0.0%N/A0.499% 5/18/2021 RA Capital Management L.P.1,388,888$22.99M0.3%N/A3.419% 5/18/2021 Orbimed Advisors LLC1,584,845$26.23M0.2%N/A3.901% 5/18/2021 Redmile Group LLC2,088,089$34.56M0.5%N/A5.140% 5/18/2021 Alyeska Investment Group L.P.32,230$533K0.0%N/A0.079% 5/18/2021 Boxer Capital LLC1,536,208$25.42M0.9%N/A3.782% 5/18/2021 Citadel Advisors LLC39,253$650K0.0%N/A0.097% 5/17/2021 Deerfield Management Company L.P. Series C800,000$13.24M0.3%N/A1.969% 5/17/2021 Perceptive Advisors LLC755,375$12.50M0.2%N/A1.860% 5/17/2021 Woodline Partners LP238,822$3.95M0.1%N/A0.588% 5/17/2021 Caas Capital Management LP50,000$828K0.0%N/A0.123% 5/17/2021Pinz Capital Management LP6,203$103K0.0%N/A0.015% 5/17/2021 Sphera Funds Management LTD.300,000$4.97M0.4%N/A0.739% 5/14/2021 Monashee Investment Management LLC125,000$2.07M0.3%N/A0.308% 5/12/2021 Pura Vida Investments LLC103,026$1.71M0.0%N/A0.254% 5/12/2021 JPMorgan Chase & Co.625,750$10.36M0.0%N/A1.540% 5/11/2021 Peregrine Capital Management LLC322,261$5.33M0.1%N/A0.793% 5/11/2021 Landscape Capital Management L.L.C.12,540$208K0.0%N/A0.031% 5/7/2021BlackRock Inc.25,000$413K0.0%N/A0.062% (Data available from 1/1/2016 forward) ACHL Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ACHL shares? During the previous two years, 13 institutional investors and hedge funds held shares of Achilles Therapeutics. The most heavily invested institutionals were BML Capital Management LLC ($4.18M), Fcpm Iii Services B.V. ($2.13M), Ikarian Capital LLC ($1.80M), StemPoint Capital LP ($1.73M), Baker BROS. Advisors LP ($1.51M), RA Capital Management L.P. ($1.45M), and Artal Group S.A. ($944K).Learn more on ACHL's institutional investors. What percentage of Achilles Therapeutics stock is owned by institutional investors? 56.38% of Achilles Therapeutics stock is owned by institutional investors. Learn more on ACHL's institutional investor holdings. Which institutional investors have been buying Achilles Therapeutics stock? The following institutional investors have purchased Achilles Therapeutics stock in the last 24 months: BML Capital Management LLC ($3.47M), Fcpm Iii Services B.V. ($2.39M), Ikarian Capital LLC ($1.44M), StemPoint Capital LP ($1.39M), Acadian Asset Management LLC ($280.93K), Vestal Point Capital LP ($108.08K), and Forefront Analytics LLC ($45.10K). How much institutional buying is happening at Achilles Therapeutics? Institutional investors have bought a total of 9,164,362 shares in the last 24 months. This purchase volume represents approximately $9.73M in transactions. Which Achilles Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Achilles Therapeutics stock in the last 24 months: RA Capital Management L.P. ($3.41M), Artal Group S.A. ($1.50M), Baker BROS. Advisors LP ($894.02K), Renaissance Technologies LLC ($323.03K), Acadian Asset Management LLC ($30.10K), and Virtu Financial LLC ($18.65K). How much institutional selling is happening at Achilles Therapeutics? Institutional investors have sold a total of 6,172,645 shares in the last 24 months. This volume of shares sold represents approximately $6.37M in transactions. Related Companies ACTU Major Shareholders SCPH Major Shareholders INZY Major Shareholders KYTX Major Shareholders NKTX Major Shareholders GALT Major Shareholders TNYA Major Shareholders LFVN Major Shareholders OGI Major Shareholders TSVT Major Shareholders This page (NASDAQ:ACHL) was last updated on 11/23/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Achilles Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Achilles Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
